Correction to: Type I Interferon Receptor Deficiency in Dendritic Cells Facilitates Systemic Murine Norovirus Persistence Despite Enhanced Adaptive Immunity (PLOS Pathogens, (2016), 12, 6, (e1005684), 10.1371/journal.ppat.1005684);Type I Interferon Receptor Deficiency in Dendritic Cells Facilitates Systemic Murine Norovirus Persistence Despite Enhanced Adaptive Immunity

PLoS Pathogens

Volumn 12, Issue 6, 2016, Pages

  Nice, Timothy J ^a   Osborne, Lisa C ^b   Tomov, Vesselin T ^c   Artis, David ^d   Wherry, E John ^c   Virgin, Herbert W ^e  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN P 15095; INTERFERON RECEPTOR; ALPHA BETA INTERFERON RECEPTOR; INTERFERON;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE DOSAGE; MOUSE; NONHUMAN; NOROVIRUS; NOROVIRUS INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS REPLICATION; ANIMAL; C57BL MOUSE; CALICIVIRUS INFECTION; DEFICIENCY; DISEASE MODEL; FLOW CYTOMETRY; IMMUNOLOGY; INNATE IMMUNITY; KNOCKOUT MOUSE; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; VIROLOGY;

ADAPTIVE IMMUNITY; ANIMALS; CALICIVIRIDAE INFECTIONS; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNITY, INNATE; INTERFERON TYPE I; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NOROVIRUS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, INTERFERON ALPHA-BETA; VIRUS REPLICATION;

EID: 84978864753     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1006223     Document Type: Erratum

References (35)

1. Ng CT, Sullivan BM, Oldstone MB, The role of dendritic cells in viral persistence. Curr Opin Virol. 2011;1: 160–166. doi: 10.1016/j.coviro.2011.05.00621909344
2. Shin H, Wherry EJ, CD8 T cell dysfunction during chronic viral infection. Curr Opin Immunol. 2007;19: 408–415. doi: 10.1016/j.coi.2007.06.00417656078
3. Virgin HW, Wherry EJ, Ahmed R, Redefining Chronic Viral Infection. Cell. 2009;138: 30–50. doi: 10.1016/j.cell.2009.06.03619596234
4. Bergmann CC, Lane TE, Stohlman SA, Coronavirus infection of the central nervous system: host–virus stand-off. Nat Rev Microbiol. 2006;4: 121–132. doi: 10.1038/nrmicro134316415928
5. Wherry EJ, Blattman JN, Murali-Krishna K, van der Most R, Ahmed R, Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J Virol. 2003;77: 4911–27. 12663797
6. Barber DL, Wherry EJ, Masopust D, Zhu B, Allison JP, Sharpe AH, et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature. 2006;439: 682–687. doi: 10.1038/nature0444416382236
7. Bergmann CC, Altman JD, Hinton D, Stohlman SA, Inverted immunodominance and impaired cytolytic function of CD8+ T cells during viral persistence in the central nervous system. J Immunol. 1999;163: 3379–87. 10477608
8. Ramakrishna C, Stohlman SA, Atkinson RA, Hinton DR, Bergmann CC, Differential Regulation of Primary and Secondary CD8+ T Cells in the Central Nervous System. J Immunol. 2004;173: 6265–6273. doi: 10.4049/jimmunol.173.10.626515528365
9. Hsu CC, Riley LK, Wills HM, Livingston RS, Persistent infection with and serologic cross-reactivity of three novel murine noroviruses. Comp Med. 2006;56: 247–51. 16941951
10. Thackray LB, Wobus CE, Chachu KA, Liu B, Alegre ER, Henderson KS, et al. Murine Noroviruses Comprising a Single Genogroup Exhibit Biological Diversity despite Limited Sequence Divergence. J Virol. 2007;81: 10460–10473. doi: 10.1128/JVI.00783-0717652401
11. Saito M, Goel-Apaza S, Espetia S, Velasquez D, Cabrera L, Loli S, et al. Multiple Norovirus Infections in a Birth Cohort in a Peruvian Periurban Community. Clin Infect Dis. 2014;58: 483–491. doi: 10.1093/cid/cit76324300042
12. Atmar RL, Opekun AR, Gilger MA, Estes MK, Crawford SE, Neill FH, et al. Norwalk Virus Shedding after Experimental Human Infection. Emerg Infect Dis. 2008;14: 1553–1557. doi: 10.3201/eid1410.08011718826818
13. Nice TJ, Strong DW, McCune BT, Pohl CS, Virgin HW, A Single-Amino-Acid Change in Murine Norovirus NS1/2 Is Sufficient for Colonic Tropism and Persistence. J Virol. 2013;87: 327–334. doi: 10.1128/JVI.01864-1223077309
14. Baldridge MT, Nice TJ, McCune BT, Yokoyama CC, Kambal A, Wheadon M, et al. Commensal microbes and interferon-λ determine persistence of enteric murine norovirus infection. Science (80-). 2015;347: 266–269. doi: 10.1126/science.1258025
15. Nice TJ, Baldridge MT, McCune BT, Norman JM, Lazear HM, Artyomov M, et al. Interferon-λ cures persistent murine norovirus infection in the absence of adaptive immunity. Science (80-). 2015;347: 269–273. doi: 10.1126/science.1258100
16. Lazear HM, Nice TJ, Diamond MS, Interferon-λ: Immune Functions at Barrier Surfaces and Beyond. Immunity. Elsevier Inc.; 2015;43: 15–28. doi: 10.1016/j.immuni.2015.07.001
17. Thackray LB, Duan E, Lazear HM, Kambal A, Schreiber RD, Diamond MS, et al. Critical Role for Interferon Regulatory Factor 3 (IRF-3) and IRF-7 in Type I Interferon-Mediated Control of Murine Norovirus Replication. J Virol. 2012;86: 13515–13523. doi: 10.1128/JVI.01824-1223035219
18. Karst SM, Wobus CE, Lay M, Davidson J, Virgin HW, STAT1-dependent innate immunity to a Norwalk-like virus. Science (80-). 2003;299: 1575–8. doi: 10.1126/science.1077905
19. Wobus CE, Karst SM, Thackray LB, Chang K-O, Sosnovtsev S V., Belliot G, Michael Emerman, et al. Replication of Norovirus in Cell Culture Reveals a Tropism for Dendritic Cells and Macrophages. PLoS Biol. 2004;2: e432. doi: 10.1371/journal.pbio.002043215562321
20. Bachmann MF, Kopf M, The role of B cells in acute and chronic infections. Curr Opin Immunol. 1999;11: 332–9. 10375561
21. Tomov VT, Osborne LC, Dolfi D V, Sonnenberg GF, Monticelli L a, Mansfield K, et al. Persistent Enteric Murine Norovirus Infection Is Associated with Functionally Suboptimal Virus-Specific CD8 T Cell Responses. J Virol. 2013;87: 7015–7031. doi: 10.1128/JVI.03389-1223596300
22. Wherry EJ, Ha S-J, Kaech SM, Haining WN, Sarkar S, Kalia V, et al. Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection. Immunity. 2007;27: 824. doi: 10.1016/j.immuni.2007.11.006
23. Jones MK, Watanabe M, Zhu S, Graves CL, Keyes LR, Grau KR, et al. Enteric bacteria promote human and mouse norovirus infection of B cells. Science (80-). 2014;346: 755–759. doi: 10.1126/science.1257147
24. Chachu KA, LoBue AD, Strong DW, Baric RS, Virgin HW, Estes MK, Immune Mechanisms Responsible for Vaccination against and Clearance of Mucosal and Lymphatic Norovirus Infection. PLoS Pathog. 2008;4: e1000236. doi: 10.1371/journal.ppat.100023619079577
25. Ou R, Zhou S, Huang L, Moskophidis D, Critical role for alpha/beta and gamma interferons in persistence of lymphocytic choriomeningitis virus by clonal exhaustion of cytotoxic T cells. J Virol. 2001;75: 8407–23. 11507186
26. Wilson EB, Yamada DH, Elsaesser H, Herskovitz J, Deng J, Cheng G, et al. Blockade of Chronic Type I Interferon Signaling to Control Persistent LCMV Infection. Science (80-). 2013;340: 202–207. doi: 10.1126/science.1235208
27. Teijaro JR, Ng C, Lee AM, Sullivan BM, Sheehan KCF, Welch M, et al. Persistent LCMV Infection Is Controlled by Blockade of Type I Interferon Signaling. Science (80-). 2013;340: 207–211. doi: 10.1126/science.1235214
28. Shaabani N, Khairnar V, Duhan V, Zhou F, Tur RF, Häussinger D, et al. Two separate mechanisms of enforced viral replication balance innate and adaptive immune activation. J Autoimmun. 2016;67: 82–9. doi: 10.1016/j.jaut.2015.10.00426553386
29. Nakayama Y, Plisch EH, Sullivan J, Thomas C, Czuprynski CJ, Williams BRG, Baric RS, et al. Role of PKR and Type I IFNs in Viral Control during Primary and Secondary Infection. PLoS Pathog. 2010;6: e1000966. doi: 10.1371/journal.ppat.100096620585572
30. Richter K, Brocker T, Oxenius A, Antigen amount dictates CD8+T-cell exhaustion during chronic viral infection irrespective of the type of antigen presenting cell. Eur J Immunol. 2012;42: 2290–2304. doi: 10.1002/eji.20114227522653665
31. McCartney SA, Thackray LB, Gitlin L, Gilfillan S, Virgin HW, IVColonna M, Baric RS, MDA-5 Recognition of a Murine Norovirus. PLoS Pathog. 2008;4: e1000108. doi: 10.1371/journal.ppat.100010818636103
32. Mahlakõiv T, Hernandez P, Gronke K, Diefenbach A, Staeheli P, Greenberg HB, Leukocyte-Derived IFN-α/β and Epithelial IFN-λ Constitute a Compartmentalized Mucosal Defense System that Restricts Enteric Virus Infections. PLOS Pathog. 2015;11: e1004782. doi: 10.1371/journal.ppat.100478225849543
33. Li X-D, Sun L, Seth RB, Pineda G, Chen ZJ, Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc Natl Acad Sci. 2005;102: 17717–17722. doi: 10.1073/pnas.050853110216301520
34. Cadwell K, Liu JY, Brown SL, Miyoshi H, Loh J, Lennerz JK, et al. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature. 2008;456: 259–263. doi: 10.1038/nature0741618849966
35. Osborne LC, Monticelli LA, Nice TJ, Sutherland TE, Siracusa MC, Hepworth MR, et al. Virus-helminth coinfection reveals a microbiota-independent mechanism of immunomodulation. Science (80-). 2014;345: 578–582. doi: 10.1126/science.1256942